Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 10/20 | 0.40 |
| ▸ | CTSV | O60911 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 3/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7778926 | 0.88 | KIF11 (0.41) | ADRB2CTSVCTSLKIF11THRB | |
| SCHEMBL7778742 | 0.85 | CTSV (0.42) | ADRB2CTSVCTSLKIF11NR1I2 | |
| SCHEMBL7781279 | 0.83 | KIF11 (0.39) | ADRB2CTSVCTSLKIF11NR1I2 | |
| SCHEMBL6916813 | 0.80 | ADRB2 (0.53) | ADRB2CTSVCTSLKIF11NR1I2 | |
| SCHEMBL7778756 | 0.80 | CTSV (0.38) | ADRB2CTSVCTSLKIF11THRB | |
| Hydrochloric Acid SCHEMBL7107443 | 0.80 | ADRB2 (0.52) | ADRB2CTSVCTSLKIF11NR1I2 | |
| SCHEMBL7782053 | 0.76 | CTSV (0.43) | CTSVCTSLCYP19A1HTT | |
| Acetic Acid SCHEMBL7113426 | 0.76 | ADRB2 (0.50) | ADRB2CTSVCTSLNR1I2ADRB1 | |
| SCHEMBL7113431 | 0.75 | ADRB2 (0.41) | ADRB2CTSVCTSLKIF11NR1I2 | |
| SCHEMBL12886607 | 0.74 | MAOA (0.57) | CTSVCTSLKIF11NR1I2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1128845-A1 | COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTDIABETIC AGENT | SMITHKLINE BEECHAM PLC (GB) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000027434-A1 | COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTIDIABETIC AGENT | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-05-18 | — | — | WO | disclosed |